作者：
Wright, R. Scott [1]
;
Ray, Kausik K. [2]
;
Raal, Frederick J. [3]
;
Kallend, David G. [4]
;
Jaros, Mark [5]
;
Koenig, Wolfgang [6]
;
Leiter, Lawrence A. [7]
;
Landmesser, Ulf [8]
;
Schwartz, Gregory G. [9]
;
Friedman, Andrew [10]
;
Wijngaard, Peter L. J. [11]
;
Conde, Lorena Garcia [12]
;
Kastelein, John J. P.
作者单位：
Novartis Pharma AG, Basel, Switzerland
[1]
Imperial Coll, Dept Primary Care & Publ Hlth, Imperial Ctr Cardiovasc Dis Prevent, London, England
[2]
Summit Analyt, Denver, CO USA
[3]
Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada
[4]
Mayo Clin, Div Prevent Cardiol, Rochester, MN USA
[5]
Tech Univ Munich, DZHK German Ctr Cardiovasc Res, Deutsches Herzzentrum Munchen, Munich Heart
[6]
Charite Univ Med Berlin, Berlin Inst Hlth BIH, Dept Cardiol, DZHK, Partner Site, Berlin, Germany
[7]
Univ Amsterdam, Acad Med Ctr, Amsterdam, Netherlands
[8]
Univ Colorado, Sch Med, Div Cardiol, Aurora, CO USA
[9]
Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa
[10]
Med Co, Zurich, Switzerland
[11]
Novartis Pharmaceut, E Hanover, NJ USA
[12]
发布时间
2021-06-12
换一批
换一批
